Additionally, we found a beneficial association between EGP with plasma LDL-C, suggesting LDL-C might decrease EGP and thus improve hepatic insulin sensitivity and potentially and paradoxically reduce the risk of type 2 diabetes. The gene discussed is INS; the disease is type 2 diabetes mellitus.